Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
1.280
+0.040 (3.23%)
Mar 6, 2025, 4:00 PM EST - Market closed
Zura Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM | FY 2023 | FY 2022 | FY 2022 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 |
Selling, General & Admin | 28.2 | 18.64 | 3.79 | 1.91 |
Research & Development | 22.08 | 44 | 25.84 | 45 |
Operating Expenses | 50.28 | 62.64 | 29.63 | 46.91 |
Operating Income | -50.28 | -62.64 | -29.63 | -46.91 |
Interest & Investment Income | 7.24 | 3.58 | 0.01 | - |
Other Non Operating Income (Expenses) | -6.45 | -1.5 | -0.2 | - |
Pretax Income | -47.25 | -60.56 | -29.82 | -46.91 |
Earnings From Continuing Operations | -47.25 | -60.56 | -29.82 | -46.91 |
Minority Interest in Earnings | - | 0.2 | 1.74 | - |
Net Income | -47.25 | -60.36 | -28.08 | -46.91 |
Preferred Dividends & Other Adjustments | -4.64 | 8.88 | 7.26 | - |
Net Income to Common | -42.62 | -69.24 | -35.33 | -46.91 |
Shares Outstanding (Basic) | 64 | 33 | 0 | - |
Shares Outstanding (Diluted) | 64 | 33 | 0 | - |
Shares Change (YoY) | 199.50% | 14392.36% | - | - |
EPS (Basic) | -0.66 | -2.09 | -154.88 | - |
EPS (Diluted) | -0.66 | -2.09 | -154.88 | - |
Free Cash Flow | -21.34 | -15.05 | -1.31 | -1.68 |
Free Cash Flow Per Share | -0.33 | -0.46 | -5.75 | - |
EBIT | -50.28 | -62.64 | -29.63 | -46.91 |
Source: S&P Capital IQ. Standard template.
Financial Sources.